June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Palmitate induced secretion of IL-6 and MCP-1 in orbital fibroblasts derived from patients with thyroid-associated ophthalmopathy
Author Affiliations & Notes
  • Ji-Sun Paik
    Ophthalmology and Visual Science, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea
  • Won-Kyung Cho
    Ophthalmology and Visual Science, DaeJeon St. Mary's Hospital, the Catholic University of Korea, Seoul, Republic of Korea
  • Eun-Hye Oh
    Institue of Hansen's Disease, College of Medicine, the Catholic University of Korea, Seoul, Republic of Korea
    Pathology, College of Medicine, the Catholic University of Korea, Seoul, Republic of Korea
  • Seong-Beom Lee
    Institue of Hansen's Disease, College of Medicine, the Catholic University of Korea, Seoul, Republic of Korea
    Pathology, College of Medicine, the Catholic University of Korea, Seoul, Republic of Korea
  • Suk-Woo Yang
    Ophthalmology and Visual Science, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea
  • Footnotes
    Commercial Relationships Ji-Sun Paik, None; Won-Kyung Cho, None; Eun-Hye Oh, None; Seong-Beom Lee, None; Suk-Woo Yang, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 5904. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ji-Sun Paik, Won-Kyung Cho, Eun-Hye Oh, Seong-Beom Lee, Suk-Woo Yang; Palmitate induced secretion of IL-6 and MCP-1 in orbital fibroblasts derived from patients with thyroid-associated ophthalmopathy. Invest. Ophthalmol. Vis. Sci. 2013;54(15):5904.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Orbital fibroblasts are now recognized as the key effectors in the development of thyroid associated ophthalmopathy (TAO). TAO is clinically apparent in approximately 50% of patients with Graves’ hyperthyroidism. High levels of plasma free fatty acids (FFAs) are frequently seen in patients with hyperthyroidism. Palmitate is one of the most abundant FFAs in plasma and aggravates inflammation by promoting secretion of pro-inflammatory cytokines in various cells. In the present study, we characterized orbital fibroblasts from patients with TAO and then examined the effect of palmitate on the production of pro-inflammatory cytokines and hyaluronic acid (HA) in orbital fibroblasts.

Methods: Orbital fat explants were obtained from patients with TAO undergoing orbital decompression surgery (n = 5). The fibroblasts were characterized by antibodies specific for fibroblast markers and Thy-1 by immunostaining and flow cytometry. We then investigated the capability of orbital fibroblasts to secrete cytokines and HA in response to interleukin (IL)-1β using an ELISA. The effect of palmitate on cytokine and HA production in orbital fibroblasts was examined at the protein level by ELISA and at the mRNA level by quantitative real time RT-PCR. The level of phosphorylation of MAPKs, including p38, ERK, and JNK, was measured by immunoblot analysis. We then examined the role of MAPKs on palmitate-induced cytokine production using specific inhibitors to p38, ERK, and JNK, respectively.

Results: The orbital fibroblasts from patients with TAO were Thy-1- positive fibroblasts (> 90%) with the ability to secrete IL-6, IL-8, monocyte chemotactic protein-1 (MCP-1), and HA in response to IL-1β. Treatment with palmitate induced significant production of IL-6 and MCP-1, but not IL-8 and HA, in orbital fibroblasts. IL-6 and MCP-1 expression by palmitate were differentially regulated by MAPKs. IL-6 expression was mediated by the p38, ERK, JNK pathways, whereas MCP-1 expression was mediated by ERK and JNK, but not by p38, in palmitate-treated orbital fibroblasts.

Conclusions: We show the possible involvement of palmitate in the promotion of inflammation within orbital tissues. This finding may be helpful for understanding the development of TAO in patients with hyperthyroidism.

Keywords: 637 pathology: experimental • 557 inflammation • 636 pathobiology  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×